The global commodities slump is testing the resilience of resource-driven economies, pushing currencies from Australia, Canada and Norway to lows not seen since the financial crisis.
Modular method of constructing nuclear facilities has run into problems such as costly delays and who will bear the brunt of the expense.
While investors are excited about Allergan’s pursuit of more deals, they have to hope it doesn’t bite off more than it can chew.
New orders for durable goods rose a seasonally adjusted 3.4% in June from a month earlier, the Commerce Department said.
Republic Airways said a worsening pilot shortage is forcing it to cut its flying for big U.S. airlines, hurting the regional carrier’s profit and sending its stock plummeting by half.
A group of Democratic lawmakers is proposing a bill that would make it easier for people who got rid of credit-card debt using bankruptcy to fix inaccurate credit reports.
Teva’s $40.5 billion deal to buy Allergan’s generics business looks a lower risk option than its hostile pursuit of Mylan.
The dam Beijing hastily built to hold back the selloff has sprung a major leak.
Energy-sector weakness has weighed on business investment, but with the industry showing signs of stability, capital spending should pick up.
The discovery of a trove of emails between two opposing lawyers is threatening to scuttle the $6 billion class-action antitrust settlement.